Fixed-Dose Combination Statins--Is there More Good than Harm?
Florida Atlantic UniversityControversies surrounding fixed-dose combination statins have drawn attention to Vytorin as well as issues in drug development and approval. In a lead article published in the American Journal of Cardiovascular Drugs, Charles H. Hennekens, M.D., discusses the strengths, limitations, and clinical and regulatory considerations of fixed-dose combination therapy with statins.